This cross-sectional analysis examined the association between estimated glucose disposal rate (eGDR) — a proxy for insulin resistance — and benign prostatic hyperplasia (BPH) in older men from two large national cohorts: CHARLS (China) and NHANES (USA).
Higher eGDR was inversely associated with BPH risk in both populations (CHARLS: n=4,382; NHANES: n=3,463), with a significant linear dose-response relationship on restricted cubic splines. Monocytes partially mediated the eGDR–BPH relationship in NHANES, accounting for −15.14% of the effect (p < 0.0001).
Cross-sectional design prevents causal inference. BPH ascertainment methods may differ between CHARLS and NHANES. eGDR is an estimate of insulin sensitivity, not a direct measure, which may introduce measurement error.
Improving insulin sensitivity — reflected by higher eGDR — may be associated with lower BPH risk in older men. Clinicians managing metabolic health in aging males may consider BPH as a related comorbidity worth monitoring.